| Literature DB >> 35266071 |
Gan Sun1,2,3, Luyao Qiu1,2,3, Lang Yu1,2,3, Yunfei An1,2,3,4, Yuan Ding1,2,3, Lina Zhou1,2,3, Junfeng Wu1,2,3,4, Xi Yang1,2,3,4, Zhiyong Zhang1,2,3,4, Xuemei Tang1,2,3,4, Huawei Xia5, Lili Cao5, Fuping You5, Xiaodong Zhao6,7,8,9, Hongqiang Du10,11,12,13.
Abstract
Monogenic autoinflammatory diseases (mAIDs) are a heterogeneous group of diseases affecting primarily innate immunity, with various genetic causes. Genetic diagnosis of mAIDs can assist in the patient's management and therapy. However, a large number of sporadic and familial cases remain genetically uncharacterized. Deficiency in ELF4, X-linked (DEX) is recently identified as a novel mAID. Here, we described a pediatric patient suffering from recurrent viral and bacterial respiratory infection, refractory oral ulcer, constipation, and arthritis. Whole-exome sequencing found a hemizygous variant in ELF4 (chrX:129205133 A > G, c.691 T > C, p.W231R). Using cells from patient and point mutation mice, we showed mutant cells failed to restrict viral replication effectively and produced more pro-inflammatory cytokines. RNA-seq identified several potential critical antiviral and anti-inflammation genes with decreased expression, and ChIP-qPCR assay suggested mutant ELF4 failed to bind to the promoters of these genes. Thus, we presented the second report of DEX.Entities:
Keywords: Autoinflammatory disease; ELF4; Immunodeficiency; Inborn errors of immunity; Loss of function
Mesh:
Substances:
Year: 2022 PMID: 35266071 DOI: 10.1007/s10875-022-01243-3
Source DB: PubMed Journal: J Clin Immunol ISSN: 0271-9142 Impact factor: 8.542